Pubblicazioni

Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones

2024 - CANCER RESEARCH

Lucas, Olivia; Ward, Sophia; Zaidi, Rija; Bunkum, Abigail; Frankell, Alexander M.; Moore, David A.; Hill, Mark S.; Liu, Wing Kin; Marinelli, Daniele; Lim, Emilia L.; Hessey, Sonya; Naceur-Lombardelli, Cristina; Rowan, Andrew; Mann, Sukhveer; Zhai, Haoran; Dietzen, Michelle; Ding, Boyue; Royle, Gary; Mcgranahan, Nicholas; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Swanton, Charles; Zaccaria, Simone

Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations

2023 - CANCER RESEARCH

Ferrara, R; Lo Russo, G; Ciniselli, Cm; Piva, A; Bassani, B; Jachetti, E; Calareso, G; Duroni, V; Di Gregorio, S; Proto, C; Prelaj, A; De Toma, A; Occhipinti, M; Brambilla, M; Manglaviti, S; Mazzeo, L; Rinaldi, A; Beninato, T; Ganzinelli, M; De Braud, F; Garassino, Mc; Verderio, P; Colombo, Mp; Sangaletti, S

Abstract 2380: The effect of metabolic alterations on chemo-immunotherapy response in non-small-cell lung cancer model

2022 - CANCER RESEARCH

Ndembe, Gloriana; Marabese, Mirko; Intini, Ilenia; Fabbri, Alessandra; Moro, Massimo; Occhipinti, Mario; Sottotetti, Elisa; Russo, Giuseppe Lo; Ganzinelli, Monica; Broggini, Massimo

Abstract 6307: The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, augments the antitumor efficacy of radiotherapy in treatment of human glioblastoma

2022 - CANCER RESEARCH

Colapietro, Alessandro; Yang, Peiying; Rosetti, Alessandra; Mancini, Andrea; Vital, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Luca Gravina, Giovanni; Newman, Robert; Festuccia, Claudio

Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts)

2021 - CANCER RESEARCH

Ferrara, R; Jachetti, E; Calareso, G; Brambilla, M; Lo Russo, G; Proto, C; Prelaj, A; Signorelli, D; Galli, G; De Toma, A; Occhipinti, M; Manglaviti, S; Labianca, A; Ganzinelli, M; Spano, Sm; Molino, G; Martinetti, A; Greco, Fg; Bini, M; Beninato, T; de Braud, F; Colombo, Mp; Garassino, Mc; Sangaletti, S

Targeting chromosomal passenger complex by disruption of INCENP function inhibits tumor progression in neuroblastoma

2019 - CANCER RESEARCH

Ming, Sun; Veschi, V; Norris, Lam; Sukriti, Bagchi; Man, Xu; Arnulfo, Mendoza; Zhihui, Liu; Carol, J Thiele

Epigenetic siRNA and chemical screens identify SETD8 inhibition as a therapeutic strategy to reactivate p53 in high-risk neuroblastoma

2017 - CANCER RESEARCH

Veschi, V; Zhihui, Liu; Ty, C Voss; Laurent, Ozbun; Berkley, Gryder; Chunhua, Yan; Ying, Hu; Anqi, Ma; Jian, Jin; Sharlyn, J Mazur; Norris, Lam; Barbara, K Souza; Giuseppe, Giannini; Gordon, L Hager; Cheryl, H Arrowsmith; Javed, Khan; Ettore, Appella; Carol, Thiele

Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150 increases the chemosensitivity and decreases tumor initiating potential of neuroblastoma cells

2016 - CANCER RESEARCH

Odate, Seiichi; Yan, Shuang; Veschi, V; Lam, Norris; Liu, Zhihui; Thiele Carol, J